John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$272M |
| 2 |
PayPal
PYPL
|
+$237M |
| 3 |
Tesla
TSLA
|
+$223M |
| 4 |
Advanced Micro Devices
AMD
|
+$169M |
| 5 |
Cencora
COR
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$293M |
| 2 |
JPMorgan Chase
JPM
|
+$226M |
| 3 |
GSK
GSK
|
+$219M |
| 4 |
Procter & Gamble
PG
|
+$202M |
| 5 |
Accenture
ACN
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.55% |
| 2 | Healthcare | 16.09% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SACH
2551
Sachem Capital Corp
SACH
$41.7M
| $57.3K | ﹤0.01% |
17,363
-137,462
| -89% | -$496K |
|
2552
Werewolf Therapeutics
HOWL
$42.9M
| $55.7K | ﹤0.01% |
+27,185
| New | +$71.1K |
|
2553
Trevi Therapeutics
TRVI
$2.58B
| $55.3K | ﹤0.01% |
28,653
-50,784
| -64% | -$100K |
|
|
LEV
2554
DELISTED
The Lion Electric Company
LEV
| $55K | ﹤0.01% |
+24,542
| New | +$66.4K |
|
2555
Palisade Bio
PALI
$350M
| $54.1K | ﹤0.01% |
693
+586
| +548% | +$34K |
|
|
HLGN
2556
DELISTED
Heliogen, Inc.
HLGN
| $53.4K | ﹤0.01% |
+2,186
| New | +$98.6K |
|
|
TBIO
2557
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $53.2K | ﹤0.01% |
2,463
-809
| -25% | -$22K |
|
|
MTEM
2558
DELISTED
Molecular Templates, Inc.
MTEM
| $52.9K | ﹤0.01% |
10,749
-3,871
| -26% | -$32.1K |
|
|
NSLR
2559
Neostellar Capital Corp
NSLR
$261M
| $52.9K | ﹤0.01% |
13,916
-96,926
| -87% | -$383K |
|
|
SIEN
2560
DELISTED
Sientra, Inc.
SIEN
| $52.2K | ﹤0.01% |
+25,744
| New | +$88.9K |
|
2561
Humacyte
HUMA
$184M
| $51.8K | ﹤0.01% |
+24,567
| New | +$74.6K |
|
2562
Zedge
ZDGE
$37.8M
| $51.7K | ﹤0.01% |
29,376
-20,889
| -42% | -$45.2K |
|
2563
Smith Micro Software
SMSI
$16.7M
| $50.8K | ﹤0.01% |
605
-135
| -18% | -$11.8K |
|
2564
Denison Mines
DNN
$3.2B
| $50.4K | ﹤0.01% |
+43,800
| New | +$51.9K |
|
|
PLM
2565
DELISTED
PolyMet Mining Corp.
PLM
| $50.2K | ﹤0.01% |
18,945
-9,192
| -33% | -$26.5K |
|
2566
Arlo Technologies
ARLO
$1.41B
| $50.1K | ﹤0.01% |
14,284
-124,247
| -90% | -$511K |
|
|
APTX
2567
DELISTED
Aptinyx Inc. Common Stock
APTX
| $49.7K | ﹤0.01% |
174,225
-10,300
| -6% | -$2.98K |
|
2568
Eledon Pharmaceuticals
ELDN
$277M
| $49.3K | ﹤0.01% |
21,637
-8,100
| -27% | -$20K |
|
2569
OmniAb
OABI
$685M
| $49.3K | ﹤0.01% |
+13,700
| New | +$71.9K |
|
2570
NextCure
NXTC
$27M
| $47.7K | ﹤0.01% |
2,821
-2,431
| -46% | -$55.9K |
|
2571
Pyxis Oncology
PYXS
$247M
| $47.5K | ﹤0.01% |
35,477
-2,200
| -6% | -$3.3K |
|
|
RBOT
2572
DELISTED
Vicarious Surgical
RBOT
| $47.4K | ﹤0.01% |
+783
| New | +$72.8K |
|
2573
Arqit Quantum
ARQQ
$350M
| $46.8K | ﹤0.01% |
+519
| New | +$76.2K |
|
|
MTVA
2574
MetaVia Inc
MTVA
$10.1M
| $46.7K | ﹤0.01% |
+739
| New | +$317K |
|
2575
AmeriServ Financial
ASRV
$81.7M
| $46.4K | ﹤0.01% |
11,769
| – | – |
|
Similar funds
John Overdeck's Q4 2022 Portfolio in Review
As of Q4 2022, John Overdeck held 3,245 positions worth $31.9B, up 8.2% from $29.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
John Overdeck's Q4 2022 filing shows 801 new, 908 increased, 911 reduced and 472 closed positions. Its largest new stake was Yum! Brands: 1,187,068 shares worth $152M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $293M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q4 2022 buy was Yum! Brands: 1,187,068 shares worth $152M.
- John Overdeck added most to Amazon in Q4 2022, an estimated $272M increase.
- John Overdeck's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $293M.
- John Overdeck fully exited JPMorgan Chase in Q4 2022, selling an estimated $226M.
- John Overdeck's ten largest holdings make up 7.9% of its $31.9B portfolio in Q4 2022.
- John Overdeck opened 801 new positions and closed 472 in Q4 2022.
- John Overdeck's portfolio value rose 8.2% quarter-over-quarter to $31.9B.
Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.